Mexico / Bayer Targets Cancer; Novartis Gets Aggressive; J&J Vaccines Arrive; Doctors Denied Jabs
The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion…
Top Stories
Australia / Opportunities for the Life Science Industry post-COVID
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully managed to avoid the worst of the COVID-19 pandemic, providing opportunities for the life…
Egypt / Trade Deficit Plummets; Big UAE Investments; Vaccine Manufacturing Developments
As of today, the Evergreen boat that blocked global shipping when it got stuck in the Suez Canal has still not been…
China / A New Era of Reform Transforming Regulatory Professionals
Writing in the June edition of DIA’s Global Forum magazine, Harbour BioMed’s Fang Zhou, in conversation…
Development & Manufacturing / Newly Independent CDMO Skyepharma Looks to Expansion
Fresh from a management buyout and the establishment of Skyepharma as an independent company, Managing Director…
The Long Read / Dominican Republic: A Hidden Manufacturing Gem
The rise of the Dominican Republic as a regional medtech manufacturing hub might have come as a surprise to many,…
US Generics & Biosimilars / Five Takeaways from Access! 2021
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five key takeaways from the…
In Conversation
Georg Schroeckenfuchs – President & Cluster Head MEA, Novartis
Georg Schroeckenfuchs, Novartis’ president and head of the Middle East and Africa (MEA) cluster, explains how the company’s objectives are aligned with Saudi Arabia’s Vision 2030, the progress made towards the nationalization of its Saudi workforce, the potential impact of changes in the tender process, and why Novartis is uniquely positioned to build on Saudi Arabia’s clinical trial capabilities. …
Latest Reports
Focus on Vaccines
Sputnik V: A Brief History of Russia’s Controversial Viral…
Although Russian authorities received heavy criticism for approving the Sputnik…
Southeast Asia: Kalbe Underwhelms in Indonesia; Novavax…
The latest from the pharma industry in Southeast Asia, including underwhelming…
Industry Warns of Vaccine Manufacturing Bottlenecks;…
Big Pharma’s representatives are warning of upcoming bottlenecks in the…
Mexico Pharma News: Bayer Targets Cancer; Novartis Gets…
The latest news from Mexican pharma, including Bayer’s big bet on oncology and…
Read more: Vaccines >>
Focus on China
China’s New Era of Reform Transforming Regulatory…
Writing in the June edition of DIA's Global Forum magazine, Harbour BioMed's…
China Pharma News: BioNTech-Fosun JV; Patent Law Revamp;…
The latest news from Chinese pharma, including an overhaul of the country’s…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
HKEX’s Aim to Become World’s #1 Biotech Listing Hub…
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s…
Read more: China >>
Focus on USA
If the “Primary Endpoint” in an…
Taking the example of music's effect on Alzheimer's disease patients, John G…
Aducanumab Approval: Opening the Floodgates for a New Era of…
With the US FDA’s controversial recent decision to approve Biogen and…
USA: Importance of the Patient Voice in Drug Development:…
Writing in the May edition of DIA’s Global Forum magazine, Erica Lyons, Sarrit…
Impact of COVID-19 on US Clinical Studies Conducted by…
Writing in the June edition of DIA’s Global Forum magazine, representatives of…
Read more: USA >>
Focus on Singapore
Singapore: Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long…
Varian’s Kenneth Tan on the Future of Cancer Care in…
Kenneth Tan has been President for Asia Pacific & Japan at cancer-focused…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
The Challenges of Regulatory Convergence in APAC Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific…
Read more: Singapore >>
Focus on MEA
MENA Pharma News: Egypt Opens ‘Pharma City’;…
The latest Middle East and North Africa (MENA) pharma, including Egypt’s…
The Skills That Regional Pharma Leaders Need in the Middle…
Mohamed Nasser, Amgen’s general manager for the vast Middle East & Africa…
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…
Egypt Pharma Update: Trade Deficit Plummets; Big UAE…
As of today, the Evergreen boat that blocked global shipping when it got stuck…
Read more: MEA >>
Focus on Switzerland
What Switzerland Means to Novartis & Roche
The Novartis and Roche names are synonymous with Swiss pharmaceutical…
Switzerland’s Upcoming Cost Containment Packages:…
While once considered the land of milk and honey within Europe in terms of…
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
Lonza Goes Big with Swiss Investments in Biologics, ADCs…
In the last month alone, CDMO giant Lonza has announced three major upgrades to…
Read more: Switzerland >>
Focus on Europe
Tillotts CEO Talks SME M&A Principles
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty…
Vaccine Wars: What the EU/AstraZeneca Row Shows Us About…
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and…
Switzerland’s Upcoming Cost Containment Packages:…
While once considered the land of milk and honey within Europe in terms of…
MSD Switzerland AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich…